Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006520
Filing Date
2024-11-14
Accepted
2024-11-14 09:30:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 KYMERA THERAPEUTICS, INC. p24-3101sc13ga.htm SC 13G/A 60853
  Complete submission text file 0000902664-24-006520.txt   62562
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 212-937-4975
Avoro Capital Advisors LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Subject) CIK: 0001815442 (see all company filings)

EIN.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91636 | Film No.: 241457789
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)